Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial
2016 ◽
Vol 6
(2)
◽
pp. 155-163
◽
2014 ◽
Vol 113
(6)
◽
pp. 936-944
◽
2021 ◽
Vol 77
(11)
◽
pp. 1483-1484
2011 ◽
Vol 64
(10)
◽
pp. 853-861
◽
2004 ◽
Vol 93
(1)
◽
pp. 69-72
◽